상세 보기
자료 필터
자료유형
발행연도
2022 ~ 2025
2022 2025
키워드
언어
전체 34건 중 21번부터 30번까지의 결과를 표시합니다.
2024
Article
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results
- Schmid, Peter ;
- Turner, Nicholas C. ;
- Barrios, Carlos H. ;
- Isakoff, Steven J. ;
- Kim, Sung-Bae ;
- ... Chae, Yeesoo ;
- 외 22명
- 2024-02-16
- Clinical Cancer Research
- AMER ASSOC CANCER RESEARCH
Article
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)
- Baek, Sun Kyung ;
- Jeong, Jae-ho ;
- Jung, Kyunghae ;
- Ahn, Hee Kyung ;
- Kim, Min Hwan ;
- ... Chae, Yeesoo ;
- 외 21명
- 2024
- Therapeutic Advances in Medical Oncology
- SAGE PUBLICATIONS LTD
2023
Article
T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04
- Tsurutani, Junji ;
- Modi, Shanu ;
- Sohn, Joo Hyuk ;
- Tokunaga, Eriko ;
- Niikura, Naoki ;
- ... Chae, Yee Soo ;
- 외 11명
- 2023-11
- Annals of Oncology
- ELSEVIER
Article
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer
- Seo, Seyoung ;
- Keam, Bhumsuk ;
- Shin, Seong Hoon ;
- Chae, Yee Soo ;
- Kim, Tae Min ;
- 외 4명
- 2023-10-15
- International Journal of Cancer
- WILEY
Article
Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC)
- Tsurutani, J. ;
- Jacot, W. ;
- Yamashita, T. ;
- Riaz, F. ;
- Yerushalmi, R. ;
- ... Chae, Y. ;
- 외 14명
- 2023-10
- Annals of Oncology
- ELSEVIER
Article
Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study
- Lee, Jeeyeon ;
- Jung, Jin Hyang ;
- Kim, Wan Wook ;
- Kang, Byeongju ;
- Keum, Heejung ;
- ... Chae, Yee Soo ;
- ... Lee, Soo Jung ;
- ... Park, Ji-Young ;
- ... Park, Nora Jee-Young ;
- ... Jung, Tae-Du ;
- ... Park, Ho Yong
- 2023-08
- Annals of Surgical Oncology
- SPRINGER
Article
ASO Visual Abstract: Ten-Year Oncologic Outcomes in T1-3N1 Breast Cancer After Targeted Axillary Sampling: A Retrospective Study
- Lee, Jeeyeon ;
- Jung, Jin Hyang ;
- Kim, Wan Wook ;
- Kang, Byeongju ;
- Keum, Heejung ;
- ... Chae, Yee Soo ;
- ... Lee, Soo Jung ;
- ... Park, Ji-Young ;
- ... Park, Nora Ji-Young ;
- ... Jung, Tae-Du ;
- ... Park, Ho Yong
- 2023-05-24
- Annals of Surgical Oncology
- SPRINGER
Article
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial
- Pivot, Xavier ;
- Cortes, Javier ;
- Lueftner, Diana ;
- Lyman, Gary H. ;
- Curigliano, Giuseppe ;
- ... Chae, Yee Soo ;
- 외 14명
- 2023-04
- JAMA NETWORK OPEN
- AMER MEDICAL ASSOC
2022
Article
Oncologic necessity for the complete removal of residual microcalcifications after neoadjuvant chemotherapy for breast cancer
- Lee, Jeeyeon ;
- Park, Nora Jee-Young ;
- Park, Ho Yong ;
- Kim, Wan Wook ;
- Kang, Byeongju ;
- ... Kim, Hye Jung ;
- ... Kim, Won Hwa ;
- ... Chae, Yee Soo ;
- ... Lee, Soo Jung ;
- ... Park, Ji-Young ;
- ... Jung, Jin Hyang ;
- 외 2명
- 2022-12
- Scientific Reports
- NATURE PORTFOLIO
Article
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
- Modi, Shanu ;
- Jacot, William ;
- Yamashita, Toshinari ;
- Sohn, Joohyuk ;
- Vidal, Maria ;
- ... Chae, Yee Soo ;
- 외 32명
- 2022-07-07
- New England Journal of Medicine
- MASSACHUSETTS MEDICAL SOC